~~<i id='BC43EFAE25'><strike id='BC43EFAE25'><tt id='BC43EFAE25'><pre id='BC43EFAE25'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

fashion

author：explore 2025-09-06 02:11:27 - browse：62

Three sales executives, all of them women, have filed suit against Grail, a cancer diagnostics company, alleging that they were harassed, that the company failed to take corrective action, and that it retaliated by removing them from consideration for promotions.

The suits, which were filed earlier this week, are complicated by the fact that Grail was purchased by Illumina, the largest DNA sequencing firm, for $8 billion in 2021 — yet Illumina has left Grail to operate as a separate company. Illumina is named in the suit.

All three plaintiffs are being represented by the Vora Law Firm, based in Santa Monica, Calif.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： RSV shot was 90% effective at preventing hospitalizations in kids

focus

leisure time

knowledge

focus

AdobeAfewyearsago,Iworkedwithapatientcloseto100yearsold.Shehaddiabetesformostofheradultlife,whichaff

WSS

The Readout: Amylyx, Alumis, and Lundbeck drug updates

Gain of function research would be limited under House proposal

Amylyx ALS drug failure raises questions and concerns

Poor hospice wound care hurts patients and families

A daunting task: navigating dual Medicare, Medicaid eligibility

Congress must reauthorize a committee to support older Americans

leisure time

fashion

focus

Tori Bowie and the unacceptable rates of Black maternal death

Readout LOUD podcast: A CRISPR milestone, biotech mixology

The high cost of giving birth even with insurance

Astellas still sees hope in its gene therapy after four deaths

Wildfire smoke exposes gaps in outdoor worker protections

Why medical students are struggling with mental health

In Memoriam: Notable people who died in 2023

First medicine developed to treat MASH expected to be approved soon

Novavax promises a turnaround & Lilly roils the obesity market

PBM reforms clear House panel

focus

PBM reforms clear House panel

PBM reforms clear House panel

Childhood cancer progress stalls for Black, Hispanic kids: Report

Headspace, Meta partner to launch VR meditation app for Quest

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

leisure time

knowledge

knowledge

focus